Racial differences in the utilization of oral anticoagulant therapy in heart failure: A study of elderly hospitalized patients

Said A. Ibrahim, Chian K Kwoh, Dwain L. Harper, David W. Baker

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

To assess racial differences in the use of oral anticoagulant therapy for patients with heart failure, we conducted a cohort study of 30 hospitals in northeast Ohio. For 12,911 Medicare enrolles consecutively admitted in 1992 through 1994 with heart failure, crude and adjusted odds of being on oral anticoagulation were determined. The crude and adjusted odds of being African Americans on oral anticoagulant therapy relative to whites were 0.57 (95% confidence interval 0.47-0.69) and 0.55 (95% confidence interval 0.45- 0.67), respectively. African-Americans with heart failure were much less likely than whites to receive oral anticoagulant therapy, even after adjusting for other variables associated with anticoagulant use.

Original languageEnglish (US)
Pages (from-to)134-137
Number of pages4
JournalJournal of General Internal Medicine
Volume15
Issue number2
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Anticoagulants
Heart Failure
African Americans
Confidence Intervals
Therapeutics
Medicare
Cohort Studies

Keywords

  • Anticoagulation
  • Heart failure
  • Race

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Racial differences in the utilization of oral anticoagulant therapy in heart failure : A study of elderly hospitalized patients. / Ibrahim, Said A.; Kwoh, Chian K; Harper, Dwain L.; Baker, David W.

In: Journal of General Internal Medicine, Vol. 15, No. 2, 2000, p. 134-137.

Research output: Contribution to journalArticle

@article{969724c146fd4691851c2dff58bb9b7b,
title = "Racial differences in the utilization of oral anticoagulant therapy in heart failure: A study of elderly hospitalized patients",
abstract = "To assess racial differences in the use of oral anticoagulant therapy for patients with heart failure, we conducted a cohort study of 30 hospitals in northeast Ohio. For 12,911 Medicare enrolles consecutively admitted in 1992 through 1994 with heart failure, crude and adjusted odds of being on oral anticoagulation were determined. The crude and adjusted odds of being African Americans on oral anticoagulant therapy relative to whites were 0.57 (95{\%} confidence interval 0.47-0.69) and 0.55 (95{\%} confidence interval 0.45- 0.67), respectively. African-Americans with heart failure were much less likely than whites to receive oral anticoagulant therapy, even after adjusting for other variables associated with anticoagulant use.",
keywords = "Anticoagulation, Heart failure, Race",
author = "Ibrahim, {Said A.} and Kwoh, {Chian K} and Harper, {Dwain L.} and Baker, {David W.}",
year = "2000",
doi = "10.1046/j.1525-1497.2000.05199.x",
language = "English (US)",
volume = "15",
pages = "134--137",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Racial differences in the utilization of oral anticoagulant therapy in heart failure

T2 - A study of elderly hospitalized patients

AU - Ibrahim, Said A.

AU - Kwoh, Chian K

AU - Harper, Dwain L.

AU - Baker, David W.

PY - 2000

Y1 - 2000

N2 - To assess racial differences in the use of oral anticoagulant therapy for patients with heart failure, we conducted a cohort study of 30 hospitals in northeast Ohio. For 12,911 Medicare enrolles consecutively admitted in 1992 through 1994 with heart failure, crude and adjusted odds of being on oral anticoagulation were determined. The crude and adjusted odds of being African Americans on oral anticoagulant therapy relative to whites were 0.57 (95% confidence interval 0.47-0.69) and 0.55 (95% confidence interval 0.45- 0.67), respectively. African-Americans with heart failure were much less likely than whites to receive oral anticoagulant therapy, even after adjusting for other variables associated with anticoagulant use.

AB - To assess racial differences in the use of oral anticoagulant therapy for patients with heart failure, we conducted a cohort study of 30 hospitals in northeast Ohio. For 12,911 Medicare enrolles consecutively admitted in 1992 through 1994 with heart failure, crude and adjusted odds of being on oral anticoagulation were determined. The crude and adjusted odds of being African Americans on oral anticoagulant therapy relative to whites were 0.57 (95% confidence interval 0.47-0.69) and 0.55 (95% confidence interval 0.45- 0.67), respectively. African-Americans with heart failure were much less likely than whites to receive oral anticoagulant therapy, even after adjusting for other variables associated with anticoagulant use.

KW - Anticoagulation

KW - Heart failure

KW - Race

UR - http://www.scopus.com/inward/record.url?scp=0033976127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033976127&partnerID=8YFLogxK

U2 - 10.1046/j.1525-1497.2000.05199.x

DO - 10.1046/j.1525-1497.2000.05199.x

M3 - Article

C2 - 10672118

AN - SCOPUS:0033976127

VL - 15

SP - 134

EP - 137

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 2

ER -